MAM
STJ

Meeder Asset Management’s St Jude Medical STJ Stock Holding History

Meeder Asset Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-67,013
Closed -$5.37M – 1796
2016
Q4 		$5.37M Buy
67,013
+23,707
+55% +$1.88M 0.51% 53
2016
Q3 		$3.45M Buy
+43,306
New +$3.5M 0.29% 68
2016
Q1 		– Sell
-3,819
Closed -$236K – 985
2015
Q4 		$236K Sell
3,819
-4,795
-56% -$302K 0.02% 489
2015
Q3 		$543K Buy
+8,614
New +$615K 0.05% 339

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Meeder Asset Management's STJ Position: Q1 2017 in Review

Meeder Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 67,013 shares — an estimated $5.37M sold.

Meeder Asset Management first reported a position in STJ in Q3 2015 and held it in 4 quarters. The position peaked at $5.37M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Meeder Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Meeder Asset Management sold 67,013 St Jude Medical shares in Q1 2017, an estimated $5.37M.
  • Meeder Asset Management first reported a position in St Jude Medical in Q3 2015 and held it in 4 quarters.
  • Meeder Asset Management's St Jude Medical position peaked at $5.37M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Meeder Asset Management's 13F filing for Q1 2017, filed 12 May 2017.